D-0725-2016 Class III Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0725-2016 was initiated by Zydus Pharmaceuticals USA Inc on Jan 14, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification for a known degradant. The recall status is terminated (terminated Dec 18, 2020). Affected quantity: 9504 Bottles.

Recall details

Product Type
Drugs
Report Date
Mar 2, 2016
Initiation Date
Jan 14, 2016
Termination Date
Dec 18, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9504 Bottles

Product description

risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification for a known degradant.

Distribution pattern

US Nationwide including Puerto Rico

Code information

Lot #: MP4967, Expiry: 04/2016.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0725-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0725-2016. Report a data issue: hello@regdatalab.com.